Improvement in survival of breast cancer patients - Trends in survival over two time periods in a single institution in an Asia Pacific country, Malaysia

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 2, 2011, Pages 345-349

  Taib, Nur Aishah ^a   Akmal, M N ^b   Mohamed, I ^b   Yip, Cheng Har ^a  

^a UNIVERSITY MALAYA MEDICAL CENTRE   (Malaysia)

^b UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Breast cancer; Malaysia; Prognostic factors; Survival

Indexed keywords

EID: 79958790195     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Aryandono T, Harijadi, Soeripto (2006). Breast cancer in young women: prognostic factors and clinicopathological features. Asian Pac J Cancer Prev, 7, 451-4.
2. Bloom HJ, Richardson WW (1957). Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer, 11, 359-77.
3. Bray F, McCarron P, Parkin DM (2004): The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res, 6, 229-39.
4. Breast Cancer Trialists' Collaborative Group (1998). Polychemotherapy for early breast cancer: an overview of the randomised trials. Lancet, 352, 930-42.
5. El Saghir N, Seoud M, Khalil M, et al (2006). Effects of young age at presentation on survival in breast cancer. BMC Cancer, 6, 194.
6. Elson CW, Elston IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term followup. Histopathology, 19, 403-10.
7. Kim JK, Kwak BS, Lee JS, et al (2007). Do very young Korean breast cancer patients have worse outcomes? Ann Surg Oncol, 14, 3385-91.
8. Leong BD, Chuah JA, Kumar VM, Yip CH (2007). Breast cancer in Sabah, Malaysia: a two year prospective study. Asian Pac J Cancer Prev, 8, 525-9.
9. Leong BD, Chuah JA, Kumar VM, et al (2009). Trends of breast cancer treatment in Sabah, Malaysia: a problem with lack of awareness. Singapore Med J, 50,772-6.
10. Levine M, Eisen A (2001). Anthracycline adjuvant chemotherapy: how much is enough? J Clin Oncol, 19, 599-601.
11. Lim S, Wong J, Chang J, et al (2001), Clinical features and survival analysis of 848 Asian women with invasive breast cancer: results from a single institution in Singapore. Breast Cancer Res Treat, 69, 281.
12. Lim GCC, Rampal S, Halimah Y (2008). In Cancer Incidence in Peninsular Malaysia, 2003-2005 National Cancer Registry. Kuala Lumpur.
13. Mohd Taib NA, Yip CH, Mohamed I (2008). Survival analysis of Malaysian women with breast cancer: results from the University of Malaya Medical Centre. Asian Pac J Cancer Prev, 9, 197-202.
14. Paluch-Shimon S, Wolf I, Sadetzki S, et al (2010): Association between very young age and adverse characteristics of breast cancer at presentation amongst Israeli women. Am J Clin Oncol, (in press).
15. Sankaranarayanan R, Swaminathan R, Black R (1996). Global variations in cancer survival. Cancer, 78, 2461-64.
16. Sant M, Allemani C, Berrino F, et al (2004). Breast carcinoma survival in Europe and the United States. Comparative Study. Cancer, 100, 715-22.
17. Sant M, Allemani C, Capocaccia R, et al (2003): Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe. Int J Cancer, 106, 416-22.
18. Son BH K (2006). Changing patterns in the clinical characteristics of Korean patients with breast cancer during the last 15 years. Arch Surg, 141, 155-60.
19. Yusoff AF (2005), Head of Division, Burden of Disease, Institute for Public Health NIoH, Malaysia Malaysian burden of disease and injury study. In Forum 9. Mumbai, India.
20. Yip CH, Taib NA, Mohamed I (2006). Epidemiology of breast cancer in Malaysia. Asian Pac J Cancer Prev, 7, 369-74.